Correlation Between GlaxoSmithKline PLC and Elevate Uranium
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Elevate Uranium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Elevate Uranium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Elevate Uranium, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Elevate Uranium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Elevate Uranium. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Elevate Uranium.
Diversification Opportunities for GlaxoSmithKline PLC and Elevate Uranium
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between GlaxoSmithKline and Elevate is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Elevate Uranium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevate Uranium and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Elevate Uranium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevate Uranium has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Elevate Uranium go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Elevate Uranium
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Elevate Uranium. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 5.4 times less risky than Elevate Uranium. The stock trades about 0.0 of its potential returns per unit of risk. The Elevate Uranium is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 34.00 in Elevate Uranium on August 29, 2024 and sell it today you would lose (14.00) from holding Elevate Uranium or give up 41.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Elevate Uranium
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Elevate Uranium |
GlaxoSmithKline PLC and Elevate Uranium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Elevate Uranium
The main advantage of trading using opposite GlaxoSmithKline PLC and Elevate Uranium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Elevate Uranium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevate Uranium will offset losses from the drop in Elevate Uranium's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Elevate Uranium vs. Baselode Energy Corp | Elevate Uranium vs. Isoenergy | Elevate Uranium vs. Anfield Resources | Elevate Uranium vs. Laramide Resources |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |